Yazead Buhidma
Overview
Explore the profile of Yazead Buhidma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farrell C, Buhidma Y, Mumford P, Heywood W, Hallqvist J, Flores-Aguilar L, et al.
bioRxiv
. 2025 Mar;
PMID: 40060680
Trisomy of chromosome 21, the cause of Down syndrome (DS), is the most commonly occurring genetic cause of Alzheimer's disease (AD). Here, we compare the frontal cortex proteome of people...
2.
Arber C, Belder C, Tomczuk F, Gabriele R, Buhidma Y, Farrell C, et al.
Alzheimers Dement
. 2024 Jun;
20(7):4717-4726.
PMID: 38824433
Introduction: Familial Alzheimer's disease (fAD) is heterogeneous in terms of age at onset and clinical presentation. A greater understanding of the pathogenicity of fAD variants and how these contribute to...
3.
Buhidma Y, Lama J, Duty S
Int Rev Neurobiol
. 2024 Feb;
174:99-118.
PMID: 38341233
Pain is one of the key non-motor symptoms experienced by a large proportion of people living with Parkinson's disease (PD), yet the mechanisms behind this pain remain elusive and as...
4.
Tetter S, Arseni D, Murzin A, Buhidma Y, Peak-Chew S, Garringer H, et al.
Nature
. 2023 Dec;
625(7994):345-351.
PMID: 38057661
Frontotemporal lobar degeneration (FTLD) causes frontotemporal dementia (FTD), the most common form of dementia after Alzheimer's disease, and is often also associated with motor disorders. The pathological hallmarks of FTLD...
5.
Buhidma Y, Hobbs C, Malcangio M, Duty S
NPJ Parkinsons Dis
. 2023 Apr;
9(1):69.
PMID: 37100804
Pain is a key non-motor feature of Parkinson's disease (PD) that significantly impacts on life quality. The mechanisms underlying chronic pain in PD are poorly understood, hence the lack of...
6.
Lama J, Buhidma Y, Fletcher E, Duty S
Neuronal Signal
. 2021 Dec;
5(4):NS20210026.
PMID: 34956652
Parkinson's disease (PD) is a complex, multisystem disorder characterised by α-synuclein (SNCA) pathology, degeneration of nigrostriatal dopaminergic neurons, multifactorial pathogenetic mechanisms and expression of a plethora of motor and non-motor...
7.
Buhidma Y, Rukavina K, Chaudhuri K, Duty S
NPJ Parkinsons Dis
. 2020 Jan;
6:1.
PMID: 31934609
Pain is a commonly occurring non-motor symptom of Parkinson's disease (PD). Treatment of pain in PD remains less than optimal and a better understanding of the underlying mechanisms would facilitate...
8.
Rukavina K, Leta V, Sportelli C, Buhidma Y, Duty S, Malcangio M, et al.
Curr Opin Neurol
. 2019 Jul;
32(4):579-588.
PMID: 31260418
Purpose Of Review: In this review, we discuss the most recent evidence on mechanisms underlying pathological nociceptive processing in Parkinson's disease patients, as well as novel treatment strategies. Recent Findings:...
9.
Shoaib M, Buhidma Y
Curr Neuropharmacol
. 2017 Sep;
16(4):426-437.
PMID: 28925882
Background: Before the advent of varenicline, antidepressant drugs were reported to exhibit better clinical efficacy than nicotine replacement therapy as smoking cessation aids. The most studied is bupropion, a clinically-effective...
10.
Jackson A, Silk S, Buhidma Y, Shoaib M
Addict Biol
. 2016 Jul;
22(5):1316-1328.
PMID: 27440124
There is recognition that cognitive problems can contribute to renewed drug taking in former addicts. Our previous work has indicated that current smokers show reduced performance on a probabilistic reversal...